Mark Horowitz

Dr. Awais Aftab, a clinical associate professor at Case Western Reserve University, and Dr. Mark Horowitz, a clinical research fellow in the UK, dive deep into the complexities of SSRI withdrawal. They discuss the lack of strong long-term data and how withdrawal symptoms can be mistaken for relapse. Mark shares his personal struggles with long-term withdrawal, highlighting gaps in clinician training. They explore effective tapering strategies and the importance of prioritizing patient care over exact prevalence rates.

Dr. Mark Horowitz, a leading clinician and researcher in antidepressant withdrawal, shares his personal journey and expertise. He discusses the crucial differences between withdrawal symptoms and relapse, emphasizing the importance of individualized tapering plans. Dr. Horowitz advocates for slower reductions in medication, challenging quick taper methodologies. He highlights the psychological challenges faced during withdrawal and the necessity for clinician support. The conversation reveals the disconnect between clinical guidelines and patient experiences, urging better communication in mental health care.

Dr Mark Horowitz, a psychiatrist with expertise in antidepressants, discusses safe deprescribing practices, challenges of long-term medication use, withdrawal effects, emotional numbing, and the importance of considering social factors in mental health treatment. He highlights the risks of abrupt discontinuation and the necessity for healthcare professionals to be well-informed about proper deprescribing techniques.

In this conversation, Dr. Mark Horowitz, a psychiatrist and researcher specializing in medication withdrawal, shares his firsthand insights into the complexities of antidepressant tapering. He argues that current clinical guidelines severely underestimate the intensity of withdrawal symptoms, leading many patients to feel gaslit. Dr. Horowitz clarifies the critical distinction between withdrawal and relapse, highlights the need for improved research methodologies, and advocates for a more personalized approach to depression treatment, emphasizing the importance of lifestyle changes.

Join Dr. Mark Horowitz, a trainee psychiatrist and co-founder of Outro Health, as he shares his groundbreaking insights on safely tapering off SSRIs. Mark reveals his personal battle with SSRIs and the importance of hyperbolic tapering, emphasizing slow reductions to lessen withdrawal symptoms. He discusses the misconceptions of addiction, the risks associated with antidepressants, and the alternatives to medication for mental health. Listeners gain valuable tools for reclaiming their mental health journey and understand the broader implications for those prescribed psychiatric medications.